Home › Funds › Lipe & Dalton › BAX
Lipe & Dalton position in BAX
BAXTER INTL INC · Health Care
Lipe & Dalton reported holding 170,483 shares of BAX (BAXTER INTL INC) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 2.14% of its reported portfolio and ranking #17 among its reported holdings. Lipe & Dalton has disclosed BAX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Lipe & Dalton's BAX position evolved
Lipe & Dalton first disclosed a stake in BAX in Q3 2023 at 13,180 shares (US$497K). The position peaked in Q3 2026 at 170,483 shares, worth US$4.1M. Across 13 filings, Lipe & Dalton increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 170,483 shares valued at US$4.1M — an increase of 4,500 shares quarter over quarter.. Notable position changes include a 1023% increase in Q3 2025 (shares fell 16% over the following quarter), a 29% increase in Q1 2026 (shares rose 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 13.18K | $497.00K | New |
| Q4 2023 | 13.18K | $510.00K | Hold |
| Q1 2024 | 13.18K | $563.00K | Hold |
| Q2 2024 | 12.78K | $427.00K | Reduce |
| Q3 2024 | 12.78K | $485.00K | Hold |
| Q4 2024 | 11.84K | $345.00K | Reduce |
| Q1 2025 | 11.84K | $405.00K | Hold |
| Q2 2025 | 11.84K | $358.00K | Hold |
| Q3 2025 | 132.92K | $3.03M | Add |
| Q4 2025 | 121.42K | $2.32M | Reduce |
| Q1 2026 | 156.66K | $2.63M | Add |
| Q2 2026 | 165.98K | $3.54M | Add |
| Q3 2026 | 170.48K | $4.09M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BAX and 13F data
BAX (BAXTER INTL INC) is a Health Care company. 15 other funds we track also report a position in BAX — the largest reported positions include Pzena Investment Management (US$1.39B), GREENHAVEN ASSOCIATES INC (US$304.6M), First Pacific Advisors, LP (US$162.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BAX
- Pzena Investment Management 65.30M sh · $1.39B · Q2 2026
- GREENHAVEN ASSOCIATES INC 14.29M sh · $304.56M · Q2 2026
- First Pacific Advisors, LP 7.62M sh · $162.42M · Q2 2026
More on Lipe & Dalton
FAQ
How long has Lipe & Dalton held BAX?
Lipe & Dalton has disclosed BAX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Lipe & Dalton's current position in BAX?
As of Q3 2026, Lipe & Dalton holds 170.48K shares of BAX (BAXTER INTL INC), valued at $4.09M, representing 2.14% of its reported portfolio and ranking #17.
Has Lipe & Dalton been buying or selling BAX?
In the latest 13F filing (Q3 2026), Lipe & Dalton increased its position in BAX. The position peaked in Q3 2026 at 170.48K shares.
Which other funds hold BAX?
Other major institutional holders of BAX include Pzena Investment Management, GREENHAVEN ASSOCIATES INC, First Pacific Advisors, LP, among 15 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.